Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. AGL
AGL logo

AGL Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.628
Open
0.572
VWAP
0.60
Vol
2.14M
Mkt Cap
248.88M
Low
0.572
Amount
1.27M
EV/EBITDA(TTM)
--
Total Shares
414.87M
EV
-1.27M
EV/OCF(TTM)
--
P/S(TTM)
0.04
agilon health, inc. is a healthcare company. It enables primary care physicians (PCP) to be the agents for change in the communities they serve. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing for monthly payments to manage the total healthcare needs of its physician partners’ attributed patients (or global capitation arrangements). It focuses on community-based physician groups and is built around three key elements: agilon’s platform, agilon’s long-term physician partnership approach, and agilon’s network. The agilon platform is holistic in supporting the rapid transition to a Total Care Model with technology, people, process and capital.
Show More

Events Timeline

(ET)
2026-02-25
16:20:00
Agilon Health Sees Q1 Revenue of $1.35B-$1.39B
select
2026-02-25
16:20:00
agilon Reports Q4 Revenue of $1.57B, Beating Expectations
select
2026-02-25
16:20:00
Agilon Health Sees FY26 Revenue of $5.41B-$5.58B
select
2025-11-07 (ET)
2025-11-07
07:24:17
Agilon Health Notified of Noncompliance by NYSE
select

News

PRnewswire
7.0
03-05PRnewswire
Kuehn Law Investigates Agilon Health Executives' Fiduciary Duties
  • Investigation Background: Kuehn Law, PLLC is investigating whether certain officers and directors of Agilon Health, Inc. breached their fiduciary duties to shareholders, with allegations of intentional misrepresentation in a federal securities lawsuit.
  • Misleading Financial Guidance: The lawsuit claims that Agilon Health's guidance for 2025 was recklessly issued, as executives knew or should have known that the targets were unattainable, negatively impacting the company's future financial performance.
  • Exaggerated Risk Management: It is also alleged that the immediate positive financial impact from strategic actions taken by Agilon to mitigate risks was materially overstated, leading to significant false or misleading statements about the company's business and operations during relevant periods.
  • Shareholder Rights Protection: Kuehn Law urges shareholders who purchased AGL stock prior to February 26, 2025, to contact their attorney immediately to enforce their rights within a limited timeframe, emphasizing the importance of shareholder voices in maintaining the integrity and fairness of financial markets.
Newsfilter
7.0
03-05Newsfilter
Kuehn Law Investigates Agilon Health Executives for Breach of Duties
  • Shareholder Litigation Investigation: Kuehn Law, PLLC is investigating whether Agilon Health, Inc.'s executives breached their fiduciary duties to shareholders, as the federal securities lawsuit alleges that insiders misrepresented the company's financial outlook, impacting investor decisions.
  • 2025 Financial Guidance Issues: The lawsuit claims that Agilon Health issued guidance for 2025 recklessly, knowing that the targets were unattainable, which could expose shareholders to potential financial losses due to misleading information.
  • Exaggerated Strategic Impact: The investigation also highlights that the immediate financial benefits from strategic actions taken by Agilon to mitigate risks were materially overstated, leading to false and misleading statements about the company's operations and prospects.
  • Shareholder Rights Protection: Kuehn Law urges shareholders to contact their attorney promptly to enforce their rights within a limited timeframe, emphasizing the importance of shareholder voices in maintaining the integrity and fairness of financial markets.
Businesswire
7.0
03-02Businesswire
Faruqi & Faruqi Investigates Potential Claims Against Agilon Health
  • Legal Investigation Launched: Faruq & Faruq LLP is investigating potential claims against Agilon Health, reminding investors to seek lead plaintiff status by March 2, 2026, indicating significant legal risks for the company.
  • False Statement Allegations: The lawsuit alleges that Agilon and its executives violated federal securities laws by issuing misleading guidance for 2025, resulting in investor losses when the truth emerged.
  • Stock Price Plunge: Following Agilon's August 4, 2025 press release announcing the suspension of its 2025 financial guidance, the stock plummeted 51.5% the next day, reflecting market disappointment in the company's outlook.
  • Investor Rights Protection: Faruq & Faruq encourages anyone with information regarding Agilon's conduct to contact the firm, highlighting potential liabilities the company may face in the ongoing litigation and the rights of investors to seek recovery.
Globenewswire
7.0
03-02Globenewswire
Agilon Health Faces Class Action Lawsuit Reminder
  • Class Action Reminder: The Schall Law Firm reminds investors of a class action lawsuit against Agilon Health for violations of §§10(b) and 20(a) of the Securities Exchange Act, concerning securities purchased between February 26, 2025, and August 4, 2025, with a deadline to contact the firm by March 2, 2026.
  • False Statements Allegation: The complaint alleges that Agilon made false and misleading statements regarding its 2026 guidance, which was beyond its capabilities, and overstated the effectiveness of its strategic actions to mitigate risks, resulting in investor losses when the truth emerged.
  • Legal Representation Status: The class action has not yet been certified, meaning investors are not represented by an attorney until certification occurs, and those who choose not to act will remain absent class members, potentially forfeiting their rights to recover losses.
  • Investor Rights Advocacy: The Schall Law Firm specializes in securities class action lawsuits and shareholder rights litigation, urging affected investors to join the lawsuit to seek compensation for their losses, highlighting its commitment to protecting investor rights globally.
Globenewswire
7.0
03-01Globenewswire
Class Action Lawsuit Filed Against Agilon Health, Inc.
  • Lawsuit Background: Bragar Eagel & Squire, P.C. announces a class action lawsuit against Agilon Health, Inc. on behalf of investors who purchased securities between February 26, 2025, and August 4, 2025, alleging that the company made false and misleading statements during this period, resulting in investor losses.
  • Allegation Details: The lawsuit claims that Agilon's management issued unrealistic 2025 financial guidance despite being aware of significant industry challenges and overstated the immediate financial benefits from strategic actions, misleading investors about the company's business prospects.
  • Investor Rights: Affected investors must apply by March 2, 2026, to be appointed as lead plaintiff in the lawsuit to protect their legal rights, with Bragar Eagel & Squire offering free consultations and encouraging investors to reach out for more information.
  • Law Firm Overview: Bragar Eagel & Squire, P.C. is a nationally recognized law firm specializing in representing individual and institutional investors in securities, derivative, and commercial litigation, with extensive litigation experience and a nationwide practice.
PRnewswire
7.0
02-28PRnewswire
Faruqi & Faruqi Investigates Agilon Health Securities Fraud Case
  • Legal Investigation Launched: Faruq & Faruqi is investigating Agilon Health's securities transactions between February 26 and August 4, 2025, alleging that the company and its executives violated federal securities laws, resulting in investor losses.
  • Misguided Financial Guidance: The lawsuit claims that Agilon Health's 2025 financial guidance was materially misleading as it failed to disclose the impact of industry headwinds, leading to investor losses when the true situation emerged.
  • Stock Price Plunge: Following the release of its Q2 2025 results on August 4, Agilon Health announced the suspension of its 2025 financial guidance, causing its stock to plummet by 51.5% the next day, reflecting market disappointment in the company's outlook.
  • Investor Rights Protection: Faruq & Faruqi reminds investors that March 2 is the deadline to apply to become the lead plaintiff in the class action lawsuit, encouraging affected investors to contact the firm to discuss their legal rights.
Wall Street analysts forecast AGL stock price to rise
2 Analyst Rating
Wall Street analysts forecast AGL stock price to rise
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
0.88
Averages
0.88
High
0.88
Current: 0.000
sliders
Low
0.88
Averages
0.88
High
0.88
Citi
Neutral
downgrade
AI Analysis
2026-03-03
Reason
Citi
Price Target
AI Analysis
2026-03-03
downgrade
Neutral
Reason
Citi lowered the firm's price target on Agilon Health to 75c from 85c and keeps a Neutral rating on the shares.
Barclays
Andrew Mok
Underweight
downgrade
$1
2026-02-27
Reason
Barclays
Andrew Mok
Price Target
$1
2026-02-27
downgrade
Underweight
Reason
Barclays analyst Andrew Mok lowered the firm's price target on Agilon Health to 50c from $1 and keeps an Underweight rating on the shares. The company reported a Q4 miss but guided 2026 above consensus.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for AGL
Unlock Now

Valuation Metrics

The current forward P/E ratio for agilon health inc (AGL.N) is -1.07, compared to its 5-year average forward P/E of -26.92. For a more detailed relative valuation and DCF analysis to assess agilon health inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-26.92
Current PE
-1.07
Overvalued PE
259.43
Undervalued PE
-313.27

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
104.15
Current EV/EBITDA
-0.04
Overvalued EV/EBITDA
596.62
Undervalued EV/EBITDA
-388.32

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.91
Current PS
0.05
Overvalued PS
3.91
Undervalued PS
-0.10

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what should I buy under 1.00 a share?
Intellectia · 344 candidates
Price: $0.10 - $1.00List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
ALIT logo
ALIT
Alight Inc
507.72M
UP logo
UP
Wheels Up Experience Inc
406.86M
LAB logo
LAB
Standard BioTools Inc
392.26M
GETY logo
GETY
Getty Images Holdings Inc
360.43M
BYND logo
BYND
Beyond Meat Inc
352.61M
CAN logo
CAN
Canaan Inc
345.29M
stocks which can short term gains under 1 $
Intellectia · 29 candidates
Price: $0.10 - $1.00Volume: >= 1,000,000Rsi Category: moderateRelative Vol: >= 1.50Week Price Change Pct: >= $5.00
Ticker
Name
Market Cap$
top bottom
AGL logo
AGL
agilon health inc
244.48M
ENSC logo
ENSC
Ensysce Biosciences Inc
2.26M
AERT logo
AERT
Aeries Technology Inc
21.59M
AIIO logo
AIIO
Robo.ai Inc
62.03M
SKYQ logo
SKYQ
Sky Quarry Inc
12.74M
UPXI logo
UPXI
Upexi Inc
61.39M
STOCKS BELOW $1 FOR DAY TRADE TODAY
Intellectia · 74 candidates
Price: $0.10 - $1.00Volume: >= 500,000Price Change Pct: $-5.00 - $20.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
BURU logo
BURU
NUBURU Inc
79.92M
BYND logo
BYND
Beyond Meat Inc
346.16M
PSTV logo
PSTV
Plus Therapeutics Inc
40.69M
CAN logo
CAN
Canaan Inc
421.57M
GPUS logo
GPUS
Hyperscale Data Inc
72.38M
GUTS logo
GUTS
Fractyl Health Inc
72.56M
Stocks under 1 dollar that will explode
Intellectia · 5 candidates
Market Cap: 30.00M - 2.00BRegion: USPrice: $0.05 - $1.00List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Month Price Change Pct: $-20.00 - $150.00One Month Predict Return: >= 10.0%
Ticker
Name
Market Cap$
top bottom
BURU logo
BURU
NUBURU Inc
82.91M
USEG logo
USEG
US Energy Corp
35.83M
HOWL logo
HOWL
Werewolf Therapeutics Inc
32.75M
AGL logo
AGL
agilon health inc
410.85M
SCYX logo
SCYX
SCYNEXIS Inc
34.52M
under $1.00
Intellectia · 388 candidates
Price: <= $1.00
Ticker
Name
Market Cap$
top bottom
ASST logo
ASST
Strive Inc
1.11B
UP logo
UP
Wheels Up Experience Inc
624.57M
CAN logo
CAN
Canaan Inc
498.64M
DVLT logo
DVLT
Datavault AI Inc
433.82M
BYND logo
BYND
Beyond Meat Inc
424.50M
AGL logo
AGL
agilon health inc
395.14M
stocks to buy for 1.19 i only have $10
Intellectia · 105 candidates
Price: <= $1.19Weekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
ASST logo
ASST
Strive Inc
1.11B
UP logo
UP
Wheels Up Experience Inc
624.57M
CAN logo
CAN
Canaan Inc
498.64M
CGC logo
CGC
Canopy Growth Corp
460.70M
DVLT logo
DVLT
Datavault AI Inc
433.82M
BYND logo
BYND
Beyond Meat Inc
424.50M
give me a penny stock to invest in under 1$
Intellectia · 29 candidates
Market Cap: >= 20.00MRegion: USPrice: $0.01 - $1.00Weekly Average Turnover: >= 1,000,000List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
ASST logo
ASST
Strive Inc
1.11B
UP logo
UP
Wheels Up Experience Inc
624.57M
CAN logo
CAN
Canaan Inc
498.64M
BYND logo
BYND
Beyond Meat Inc
424.50M
AGL logo
AGL
agilon health inc
395.14M
TRX logo
TRX
TRX Gold Corp
271.29M
undervalued penny stocks rn
Intellectia · 23 candidates
Market Cap: <= 1000.00MPrice: <= $5.00Beta: LowRisk, ModerateRiskWeekly Average Turnover: >= 4,000,000Pe Ttm: <= 8Ps Ratio: <= 0.50
Ticker
Name
Market Cap$
top bottom
ALIT logo
ALIT
Alight Inc
831.79M
SLS logo
SLS
Sellas Life Sciences Group Inc
779.89M
WRN logo
WRN
Western Copper and Gold Corp
721.34M
KOS logo
KOS
Kosmos Energy Ltd
617.04M
DNUT logo
DNUT
Krispy Kreme Inc
597.84M
LX logo
LX
Lexinfintech Holdings Ltd
498.06M
stock to buy under 1$ for 2026
Intellectia · 9 candidates
Market Cap: >= 20.00MPrice: <= $1.00Beta: ModerateRisk, HighRiskWeekly Average Turnover: >= 300,000Annual Revenue Yoy Growth: >= 0.0%
Ticker
Name
Market Cap$
top bottom
ASST logo
ASST
Strive Inc
1.11B
CAN logo
CAN
Canaan Inc
498.64M
AGL logo
AGL
agilon health inc
395.14M
REI logo
REI
Ring Energy Inc
203.08M
IXHL logo
IXHL
Incannex Healthcare Inc
123.43M
ARAY logo
ARAY
Accuray Inc
91.78M
best stocks under $1
Intellectia · 28 candidates
Price: <= $1.00Weekly Average Turnover: >= 1,000,000Is Optionable: True
Ticker
Name
Market Cap$
top bottom
ASST logo
ASST
Strive Inc
1.11B
UP logo
UP
Wheels Up Experience Inc
624.57M
CAN logo
CAN
Canaan Inc
498.64M
BYND logo
BYND
Beyond Meat Inc
424.50M
AGL logo
AGL
agilon health inc
395.14M
DEFT logo
DEFT
DeFi Technologies Inc
366.70M

Whales Holding AGL

C
Colonial First State Investments Limited
Holding
AGL
+13.87%
3M Return
N
Nt-Comnwlth Super Corp
Holding
AGL
+12.22%
3M Return
I
IOOF Investment Management Limited
Holding
AGL
+10.38%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is agilon health inc (AGL) stock price today?

The current price of AGL is 0.58595 USD — it has decreased -2.33

What is agilon health inc (AGL)'s business?

agilon health, inc. is a healthcare company. It enables primary care physicians (PCP) to be the agents for change in the communities they serve. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing for monthly payments to manage the total healthcare needs of its physician partners’ attributed patients (or global capitation arrangements). It focuses on community-based physician groups and is built around three key elements: agilon’s platform, agilon’s long-term physician partnership approach, and agilon’s network. The agilon platform is holistic in supporting the rapid transition to a Total Care Model with technology, people, process and capital.

What is the price predicton of AGL Stock?

Wall Street analysts forecast AGL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AGL is0.88 USD with a low forecast of 0.88 USD and a high forecast of 0.88 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is agilon health inc (AGL)'s revenue for the last quarter?

agilon health inc revenue for the last quarter amounts to 1.57B USD, increased 3.09

What is agilon health inc (AGL)'s earnings per share (EPS) for the last quarter?

agilon health inc. EPS for the last quarter amounts to -0.46 USD, increased 76.92

How many employees does agilon health inc (AGL). have?

agilon health inc (AGL) has 856 emplpoyees as of March 10 2026.

What is agilon health inc (AGL) market cap?

Today AGL has the market capitalization of 248.88M USD.